MUSCAT: Opal Bio Pharma, a health sciences company, celebrated on Wednesday the groundbreaking ceremony of the second phase of its pharmaceutical project at Khazaen Economic City.
Total investment in the project, set on a 37,000 sq metre plot, is about RO 60 million.
The factory, scheduled to commence production in the fourth quarter of 2024, will produce a range of vital drugs that will help reduce Oman’s reliance on imports and bolster national pharma security.
It will also support Oman’s positioning as a regional center for vaccine and pharma production.
Projected to be complete in two years, the plant is expected to be a new pharmaceutical landmark in Oman and the Middle East, with its products targeted for export worldwide.
Oman Observer is now on the WhatsApp channel. Click here
